Helsinki, Finland

Esko Kankuri

This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Epiheart Oy, Upm-Kymmene Corporation. Active years: 2017-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Esko Kankuri. Retrieved from https://idiyas.com/inventor/esko-kankuri

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Esko Kankuri: Innovator in Wound Healing Technologies.

Introduction

Esko Kankuri is a notable inventor from Finland, recognized for his contributions to the field of wound healing and tissue repair. His innovative work focuses on the development of advanced materials that can significantly improve healing processes.

Latest Patents

Kankuri's most recent patent is titled "Nanofibrillar Polysaccharide For Use In The Control And Prevention Of Contraction And Scarring." This invention relates to nanofibrillar polysaccharide hydrogels designed to prevent and control scarring and contraction during wound healing or tissue repair. Although he currently holds 2 patents, his research has the potential to impact medical practices significantly.

Career Highlights

Throughout his career, Kankuri has dedicated himself to exploring innovative solutions in the medical field. His work emphasizes the importance of materials science in enhancing patient outcomes during recovery from injuries.

Collaborations

Kankuri has collaborated with notable colleagues, including Antti Laukkanen and Kristo Nuutila. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of wound healing.

Conclusion

Esko Kankuri's contributions to the development of nanofibrillar polysaccharide hydrogels highlight his commitment to advancing medical technology. His innovative approach to wound healing has the potential to transform treatment methodologies and improve patient care.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…